Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

AstraZeneca scores in final lung disease drug trials

AstraZeneca scores in final lung disease drug trials from big players such as Boehringer, GlaxoSmithKline, Novartis and Forest/Almirall.

Transforming times at AstraZeneca

Transforming times at AstraZeneca In 2014 alone the company completed the acquisition of all diabetes assets from its deal with Bristol-Myers Squibb; boosted its respiratory business with the acquisition of Almirall's respiratory franchise;

AZ adds to respiratory portfolio with Actavis drugs

AZ adds to respiratory portfolio with Actavis drugs Follows deal to acquire Almirall’s franchise in asthma and COPD. AstraZeneca has expanded its presence in respiratory disease with the $700m acquisition of Actavis' portfolio in the US and Canada. ... It follows a similar deal agreed in July last year

Deal Watch table for November 2014

Deal Watch table for November 2014 Pharma business unit. Business unit divestment. 3, 200. Almirall / AstraZeneca.

AZ's new COPD therapy gets green light in Europe

AZ's new COPD therapy gets green light in Europe AZ owns the rights to develop and commercialise Duaklir in the EU after taking ownership of former partner Almirall's respiratory portfolio in a $1.2bn deal that was completed last

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics